Impact of intrinsic cooperative thermodynamics of peptide-MHC complexes on antiviral activity of HIV-specific CTL.
The antiviral activity of HIV-specific CTL is not equally potent but rather is dependent on their specificity. But what characteristic of targeted peptides influences CTL antiviral activity remains elusive. We addressed this issue based on HLA-B35-restricted CTLs specific for two overlapping immunodominant Nef epitopes, VY8 (VPLRPMTY) and RY11 (RPQVPLRPMTY). VY8-specific CTLs were more potently cytotoxic toward HIV-infected primary CD4(+) cells than RY11-specific CTLs. Reconstruction of their TCR revealed no substantial difference in their functional avidity toward cognate Ags. Instead, the decay analysis of the peptide-MHC complex (pMHC) revealed that the VY8/HLA-B35 complex could maintain its capacity to sensitize T cells much longer than its RY11 counterpart. Corroboratively, the introduction of a mutation in the epitopes that substantially delayed pMHC decay rendered Nef-expressing target cells more susceptible to CTL killing. Moreover, by using differential scanning calorimetry and circular dichroism analyses, we found that the susceptible pMHC ligands for CTL killing showed interdependent and cooperative, rather than separate or sequential, transitions within their heterotrimer components under the thermally induced unfolding process. Collectively, our results highlight the significant effects of intrinsic peptide factors that support cooperative thermodynamics within pMHC on the efficient CTL killing of HIV-infected cells, thus providing us better insight into vaccine design.
Motozono
Chihiro
C
Division of Viral Immunology, Center for AIDS Research, Kumamoto University, Kumamoto, Japan.
Yanaka
Saeko
S
Tsumoto
Kouhei
K
Takiguchi
Masafumi
M
Ueno
Takamasa
T
D002460:Cell Line; D002999:Clone Cells; D003602:Cytotoxicity, Immunologic / Q000235:genetics; D018984:Epitopes, T-Lymphocyte / Q000737:chemistry / Q000502:physiology; D015488:HIV Antigens / Q000737:chemistry / Q000276:immunology*; D015497:HIV-1 / Q000254:growth & development / Q000276:immunology; D015797:HLA-B35 Antigen / Q000737:chemistry* / Q000502:physiology; D006801:Humans; D016056:Immunodominant Epitopes / Q000737:chemistry / Q000502:physiology; D010455:Peptides / Q000737:chemistry* / Q000502:physiology; D017510:Protein Folding; D011948:Receptors, Antigen, T-Cell / Q000737:chemistry* / Q000502:physiology; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology* / Q000378:metabolism / Q000821:virology*; D013816:Thermodynamics; D054311:nef Gene Products, Human Immunodeficiency Virus / Q000737:chemistry / Q000502:physiology
D018984:Epitopes, T-Lymphocyte; D015488:HIV Antigens; D015797:HLA-B35 Antigen; D016056:Immunodominant Epitopes; D010455:Peptides; D011948:Receptors, Antigen, T-Cell; D054311:nef Gene Products, Human Immunodeficiency Virus; C514837:nef protein, Human immunodeficiency virus 1